Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
23 results
D3.288 - Evaluating the role of dust mite sensitization in the development of edible insect allergies
D3.289 - Tolerance Assessment in Children with IgE-Mediated Cow's Milk Allergy Using Different Cutoff Values of Cow’s Milk Specific IgE
D3.284 - Milk Aversion After Successful Desensitization in a Milk-Allergic Child
D3.283 - Oat-Induced Anaphylaxis: Allergenic Characterization in a Clinical Case
D3.286 - Infant feeding patterns, perinatal history and the development of food allergy in early childhood
D3.287 - Tick Bite–Induced Alpha-Gal Syndrome: A Report of Two Cases and Literature Review Focusing on Clinical Characteristics of Asian Patients
D3.291 - Molecular Identification of Heat-Stable β-Parvalbumin in megrim (Lepidorhombus boscii) as the Likely Allergen in a Child With Selective Fish Reactivity
D3.292 - Safety profile of the yellow fever vaccine in egg-allergic children
D3.308 - Kounis Syndrome: the allergic myocardial infarction
D3.313 - Recurrent Anaphylaxis with Elevated Baseline Tryptase Revealing Hereditary Alpha-Tryptasemia with Mast Cell Activation
D3.318 - Evaluation of Clinical Predictors and Serum Tryptase Levels in Systemic Mastocytosis
D3.319 - Clinical Data of Drug Induced Anaphylaxis according to the standardized European Anaphylaxis Registry (NORA)
D3.320 - Anaphylaxis by Chlorhexidine: A case series
D3.321 - Cardiac arrest after Iodixanol: a case of non-IgE mediated mast cell activation
D3.307 - Chlorhexidine-triggered anaphylaxis in a child with multisystem allergy and sickle cell disease: a diagnostic pitfall
D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset
D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study
D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes
D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria
D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download